SCHEMBL2227651

SCHEMBL2227651

CCCCc1nc(C)c(CC(=O)N(C)C)c(O)n1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 3/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
KDM4E B2RXH2 1/20 0.35
THRB P10828 1/20 0.35
ATM Q13315 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
NCEH1 Q6PIU2 1/20 0.33
TLR8 Q9NR97 1/20 0.33
TLR7 Q9NYK1 1/20 0.33
HTR6 P50406 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2229077 0.85 LMNA (0.45) LMNAALDH1A1POLBHTTRXFP1
SCHEMBL28619888 0.82 POLB (0.45) LMNAALDH1A1POLBHTTRXFP1
SCHEMBL9843881 0.81 MAPT (0.37) LMNACYP2C19ALDH1A1POLBHTT
SCHEMBL28628793 0.80 TSHR (0.53) LMNAKDM4ETSHRTLR7
SCHEMBL29703417 0.80 TSHR (0.53) LMNAKDM4ETSHRTLR7
SCHEMBL9843662 0.78 MAPT (0.37) LMNACYP2C19ALDH1A1POLBHTT
SCHEMBL8805901 0.77 ALDH1A1 (0.44) LMNAALDH1A1ATMMAPTL3MBTL1
SCHEMBL27477358 0.76 MAPT (0.38) LMNACYP2C19ALDH1A1POLBHTT
SCHEMBL30296207 0.75 MAPK1 (0.43) LMNAALDH1A1POLBKDM4ETHRB
SCHEMBL9253828 0.75 MAPK1 (0.44) LMNAALDH1A1KDM4EATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011090323-A2 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-07-28 WO claimed
CN-102666496-B Preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide BORYUNG PHARM 2015-05-20 CN disclosed
CN-102666496-B Preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide BORYUNG PHARM 2015-05-20 CN disclosed
CN-104610164-A New preparation of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidine-5-yl)-n,n-dimethylacetamide BORYUNG PHARM 2015-05-13 CN disclosed
CN-104610164-A New preparation of 2-(2-n-butyl-4-hydroxy-6-methyl-pyrimidine-5-yl)-n,n-dimethylacetamide BORYUNG PHARM 2015-05-13 CN disclosed
CN-102666496-A New preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide BORYUNG PHARM 2012-09-12 CN disclosed
CN-102666496-A New preparation method of 2- (2-N-butyl-4-hydroxy-6-methyl-pyrimidin-5-yl) -N, N-dimethylacetamide BORYUNG PHARM 2012-09-12 CN disclosed
WO-2011090323-A3 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-11-10 WO disclosed
WO-2011090323-A3 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-11-10 WO disclosed
WO-2011090323-A2 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-07-28 WO disclosed
WO-2011090323-A2 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-07-28 WO disclosed
WO-2011090323-A2 NOVEL PREPARATION METHOD OF 2-(2-N-BUTYL-4-HYDROXY-6-METHYL-PYRIMIDIN-5-YL)-N,N-DIMETHYLACETAMIDE BORYUNG PHARMACEUTICAL CO., LTD (KR) 2011-07-28 WO disclosed